Margaret Osei
Chief Executive Officer
Margaret leads the company and chairs the leadership team. She previously ran oncology partnering at a mid-size pharmaceutical company.
Team
A team built for clinical-stage work.
Scientists, clinicians, and operators who have taken programs from a protein structure to the clinic, working across two research sites.
- Team size
- 8
- Research sites
- 2
- Open roles
- 5
Leadership
Leadership team.
Daniel Kessler, MD
Chief Medical Officer
Daniel oversees clinical development across the pipeline, from first-in-human design to Phase 2 readouts. He trained as a medical oncologist.
Anjali Raman, PhD
Chief Scientific Officer
Anjali leads discovery and translational research. Her group built the structure-guided platform behind each small-molecule program.
Tomás Herrera
Chief Operating Officer
Tomás runs operations, program management, and portfolio planning. He joined from a contract research organization, where he managed multi-site trial delivery.
Research
Research team.
Lena Fischer, PhD
Vice President, Discovery
Lena leads the discovery organization and the medicinal chemistry teams that turn protein structures into development candidates.
Kenji Watanabe, PhD
Vice President, Translational Research
Kenji leads translational research across oncology and immunology, including the biomarker strategy for each clinical program.
Clinical
Clinical team.
Amara Nwosu
Vice President, Clinical Operations
Amara leads clinical operations and the site network, from site selection through database lock.
Corporate
Corporate team.
Claire Dubois
Vice President, People
Claire leads people, culture, and hiring across both research sites.
We are hiring.
5 open roles across research, clinical, and corporate. Our interview process is four steps and we aim to decide within two weeks of the final conversation.